Angela Holton
Executive Director IOVANCE Biotherapeutics, Inc.
Seminars
Wednesday 2nd December 2026
Panel Discussion: Are We Measuring the Right Things? Defining Meaningful Flow Cytometry Readouts for Cell Therapy Development
2:00 pm
- Identifying which attributes truly influence product quality and clinical performance
- Designing assay roadmaps that translate defined QTPPs and CQAs into fit for purpose analytical strategies
- Understanding where organisations still struggle to connect characterisation, potency, and clinical outcomes
